Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Higher Neural and Cognitive Changes Following Anticholinergic Versus Beta 3 Agonist Versus Placebo Treatments in Female Patients With Overactive Bladder: a Multicenter Randomized Controlled Pilot Trial

NCT03817931 is registered in ClinicalTrials.gov with Baylor Research Institute as lead sponsor.

NCT NCT03817931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03817931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Higher Neural and Cognitive Changes Following Anticholinergic Versus Beta 3 Agonist Versus Placebo Treatments in Female Patients With Overactive Bladder: a Multicenter Randomized Controlled Pilot Trial
Lead sponsor
Baylor Research Institute
Phase
Phase 4
Overall status
Completed
Start date
August 5, 2019
Completion date
February 26, 2022
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dementia, incontinence, urge, lower urinary tract symptoms, overactive bladder